Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 20 | 4 | UROLOGY & NEPHROLOGY//GASTROENTEROLOGY & HEPATOLOGY//UROL | 479829 |
| 138 | 3 | HELICOBACTER PYLORI//GASTROENTEROLOGY & HEPATOLOGY//GASTROESOPHAGEAL REFLUX DISEASE | 66701 |
| 2088 | 2 | RANITIDINE//FAMOTIDINE//NIZATIDINE | 5570 |
| 9997 | 1 | CIMETIDINE//AMNESTIC DISTURBANCE//ANESTHESIA OBSTETRICAL RANITIDINE BUPIVACAINE INTERACTION | 1132 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | CIMETIDINE | authKW | 32645 | 3% | 4% | 29 |
| 2 | AMNESTIC DISTURBANCE | authKW | 27840 | 0% | 100% | 1 |
| 3 | ANESTHESIA OBSTETRICAL RANITIDINE BUPIVACAINE INTERACTION | authKW | 27840 | 0% | 100% | 1 |
| 4 | ANESTHETIC LOCAL LIGNOCAINE | authKW | 27840 | 0% | 100% | 1 |
| 5 | CALCIUM CARBONATE FIXED DOSE COMBINATION INTERACTION WITH | authKW | 27840 | 0% | 100% | 1 |
| 6 | CAS 66357 59 3 | authKW | 27840 | 0% | 100% | 1 |
| 7 | CENTRAL NERVOUS SYSTEM REACTIONS | authKW | 27840 | 0% | 100% | 1 |
| 8 | CIC INSERM 1436 MED HOSP UNIV | address | 27840 | 0% | 100% | 1 |
| 9 | CIFENLINE | authKW | 27840 | 0% | 100% | 1 |
| 10 | CIMETIDINE DIALYSIS | authKW | 27840 | 0% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 11897 | 59% | 0% | 668 |
| 2 | Medicine, General & Internal | 890 | 14% | 0% | 161 |
| 3 | Gastroenterology & Hepatology | 804 | 9% | 0% | 97 |
| 4 | Toxicology | 204 | 5% | 0% | 54 |
| 5 | Anesthesiology | 130 | 2% | 0% | 27 |
| 6 | Psychiatry | 57 | 4% | 0% | 42 |
| 7 | Chemistry, Medicinal | 49 | 3% | 0% | 31 |
| 8 | Medicine, Research & Experimental | 22 | 3% | 0% | 33 |
| 9 | Geriatrics & Gerontology | 18 | 1% | 0% | 11 |
| 10 | Primary Health Care | 14 | 0% | 0% | 5 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CIC INSERM 1436 MED HOSP UNIV | 27840 | 0% | 100% | 1 |
| 2 | FAMILY HLTH PROGRAM INC | 27840 | 0% | 100% | 1 |
| 3 | GOOD CLIN PRACT | 27840 | 0% | 100% | 1 |
| 4 | INVEST SOBRE PORFIRINAS PORFINIAS | 27840 | 0% | 100% | 1 |
| 5 | LUNG CLIN PATHOPHYSIOL | 27840 | 0% | 100% | 1 |
| 6 | MED CLIN PHARMACOLPHARMACOPOLE MIDIPYRENE | 27840 | 0% | 100% | 1 |
| 7 | MED FAK CLIN PHARMACOL | 27840 | 0% | 100% | 1 |
| 8 | MED MED CLIN PHARMACOL S19 | 27840 | 0% | 100% | 1 |
| 9 | MONTEFIORE HOSP MED NEUROSURG | 27840 | 0% | 100% | 1 |
| 10 | PHARM PHARMACOL BIOCHEM | 27840 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 17941 | 6% | 1% | 68 |
| 2 | PHARMACY INTERNATIONAL | 16091 | 2% | 3% | 17 |
| 3 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 10784 | 4% | 1% | 48 |
| 4 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 9803 | 5% | 1% | 54 |
| 5 | CLINICAL PHARMACY | 9273 | 1% | 2% | 16 |
| 6 | CLINICAL PHARMACOKINETICS | 7719 | 2% | 1% | 26 |
| 7 | DRUG INTELLIGENCE & CLINICAL PHARMACY | 7228 | 2% | 2% | 17 |
| 8 | JOURNAL OF CLINICAL PHARMACOLOGY | 6491 | 3% | 1% | 36 |
| 9 | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS | 5854 | 3% | 1% | 29 |
| 10 | AMERICAN JOURNAL OF HOSPITAL PHARMACY | 3698 | 2% | 1% | 18 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |